170 related articles for article (PubMed ID: 22318381)
1. Disruption of TNF-α/TNFR1 function in resident skin cells impairs host immune response against cutaneous vaccinia virus infection.
Tian T; Dubin K; Jin Q; Qureshi A; King SL; Liu L; Jiang X; Murphy GF; Kupper TS; Fuhlbrigge RC
J Invest Dermatol; 2012 May; 132(5):1425-34. PubMed ID: 22318381
[TBL] [Abstract][Full Text] [Related]
2. Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.
Nie S; Cornberg M; Selin LK
J Immunol; 2009 Nov; 183(10):6554-60. PubMed ID: 19846867
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral immunity against vaccinia virus infection of mice.
Xu R; Johnson AJ; Liggitt D; Bevan MJ
J Immunol; 2004 May; 172(10):6265-71. PubMed ID: 15128815
[TBL] [Abstract][Full Text] [Related]
4. IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection.
Tian T; Jin MQ; Dubin K; King SL; Hoetzenecker W; Murphy GF; Chen CA; Kupper TS; Fuhlbrigge RC
J Immunol; 2017 Jun; 198(11):4341-4351. PubMed ID: 28468973
[TBL] [Abstract][Full Text] [Related]
5. Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus.
Freyschmidt EJ; Mathias CB; MacArthur DH; Laouar A; Narasimhaswamy M; Weih F; Oettgen HC
J Allergy Clin Immunol; 2007 Mar; 119(3):671-9. PubMed ID: 17336617
[TBL] [Abstract][Full Text] [Related]
6. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
[TBL] [Abstract][Full Text] [Related]
7. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
Lidbury BA; Ramshaw IA; Sambhi SK
Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
[TBL] [Abstract][Full Text] [Related]
8. Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses.
Freyschmidt EJ; Mathias CB; Diaz N; MacArthur DH; Laouar A; Manjunath N; Hofer MD; Wurbel MA; Campbell JJ; Chatila TA; Oettgen HC
J Immunol; 2010 Jul; 185(2):1295-302. PubMed ID: 20548030
[TBL] [Abstract][Full Text] [Related]
9. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses.
Mathurin KS; Martens GW; Kornfeld H; Welsh RM
J Virol; 2009 Apr; 83(8):3528-39. PubMed ID: 19193795
[TBL] [Abstract][Full Text] [Related]
10. Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.
Abboud G; Tahiliani V; Desai P; Varkoly K; Driver J; Hutchinson TE; Salek-Ardakani S
J Virol; 2016 Jan; 90(1):129-41. PubMed ID: 26468539
[TBL] [Abstract][Full Text] [Related]
11. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
12. Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells.
Selin LK; Santolucito PA; Pinto AK; Szomolanyi-Tsuda E; Welsh RM
J Immunol; 2001 Jun; 166(11):6784-94. PubMed ID: 11359837
[TBL] [Abstract][Full Text] [Related]
13. Filaggrin deficiency promotes the dissemination of cutaneously inoculated vaccinia virus.
Oyoshi MK; Beaupré J; Venturelli N; Lewis CN; Iwakura Y; Geha RS
J Allergy Clin Immunol; 2015 Jun; 135(6):1511-8.e6. PubMed ID: 25649082
[TBL] [Abstract][Full Text] [Related]
14. Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity.
Wijesundara DK; Tscharke DC; Jackson RJ; Ranasinghe C
PLoS One; 2013; 8(1):e55788. PubMed ID: 23383283
[TBL] [Abstract][Full Text] [Related]
15. Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation.
Scott JE; ElKhal A; Freyschmidt EJ; MacArthur DH; McDonald D; Howell MD; Leung DY; Laouar A; Manjunath N; Bianchi T; Boes M; Oettgen HC; Geha RS
J Allergy Clin Immunol; 2007 Dec; 120(6):1382-8. PubMed ID: 17889291
[TBL] [Abstract][Full Text] [Related]
16. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
17. IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17.
Kohyama S; Ohno S; Isoda A; Moriya O; Belladonna ML; Hayashi H; Iwakura Y; Yoshimoto T; Akatsuka T; Matsui M
J Immunol; 2007 Sep; 179(6):3917-25. PubMed ID: 17785829
[TBL] [Abstract][Full Text] [Related]
18. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
[TBL] [Abstract][Full Text] [Related]
19. Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.
Puissant-Lubrano B; Bossi P; Gay F; Crance JM; Bonduelle O; Garin D; Bricaire F; Autran B; Combadière B
J Clin Invest; 2010 May; 120(5):1636-44. PubMed ID: 20364089
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
Hu Z; Molloy MJ; Usherwood EJ
Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
